The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
The immune system in atherosclerosis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Self-citationRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 1×
“The NLRP3 (also known as NALP3) inflammasome has been reported to be activated by cholesterol crystals present in macrophage”
BackgroundBiological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Self-citationPLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Natural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
Self-citationYoussef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
INFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Self-citationRajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Self-citationT lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943
Self-citationThe gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S., Jonsdottir, H., Thorsteinsdottir, U., Samani, N. J., Gudmundsson, G., Grant, S. F. A., Thorgeirsson, G., et al. (2004) · Nature Genetics · doi:10.1038/ng1311 · Cited by 927
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · PubMed · Cited by 847
Self-citationLack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
Binder, C. J., Hörkkö, S., Dewan, A., Chang, M.-K., Kieu, E. P., Goodyear, C. S., Shaw, P. X., Palinski, W., Witztum, J. L., & Silverman, G. J. (2003) · Nature Medicine · doi:10.1038/nm876 · Cited by 737
Smith, J. D., Trogan, E., Ginsberg, M., Grigaux, C., Tian, J., & Miyata, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8264 · Cited by 724
Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · Circulation · doi:10.1161/circ.105.10.1158 · Cited by 707
Self-citationCardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
Lloyd-Jones, D. M. (2010) · Circulation · doi:10.1161/circulationaha.109.849166 · Cited by 705
IL-33 reduces the development of atherosclerosis
Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071868 · Cited by 642
Björkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine · doi:10.1038/nm1008 · Cited by 634
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619
Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis
Dwyer, J. H., Allayee, H., Dwyer, K. M., Fan, J., Wu, H., Mar, R., Lusis, A. J., & Mehrabian, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa025079 · Cited by 619
Palinski, W., Miller, E., & Witztum, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.821 · Cited by 590
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22809 · Cited by 562
Zhou, X., Nicoletti, A., Elhage, R., & Hansson, G. K. (2000) · Circulation · doi:10.1161/01.cir.102.24.2919 · Cited by 554
Self-citationMonoclonal T-cell proliferation and plaque instability in acute coronary syndromes.
Liuzzo, G., Goronzy, J. J., Yang, H., Kopecky, S. L., Holmes, D. R., Frye, R. L., & Weyand, C. M. (2000) · Circulation · doi:10.1161/01.cir.101.25.2883 · Cited by 552
Modulation of atherosclerosis in mice by Toll-like receptor 2
Mullick, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25482 · Cited by 549
Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target
Samuelsson, B., Morgenstern, R., & Jakobsson, P.-J. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.1 · Cited by 538
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice
Caligiuri, G., Nicoletti, A., Poirier, B., & Hansson, G. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci7272 · Cited by 530
Self-citationHeat shock proteins and immune system
Tsan, M.-F., & Gao, B. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0109005 · Cited by 471
B cell depletion reduces the development of atherosclerosis in mice
Ait-Oufella, H., Herbin, O., Bouaziz, J.-D., Binder, C. J., Uyttenhove, C., Laurans, L., Taleb, S., Van Vré, E., Esposito, B., Vilar, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100155 · Cited by 469
Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 458
Seimon, T. A., Nadolski, M. J., Liao, X., Magallon, J., Nguyen, M., Feric, N. T., Koschinsky, M. L., Harkewicz, R., Witztum, J. L., Tsimikas, S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.010 · Cited by 457
Binder, C. J., Hartvigsen, K., Chang, M.-K., Miller, M., Broide, D., Palinski, W., Curtiss, L. K., Corr, M., & Witztum, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420479 · Cited by 452
Davenport, P., & Tipping, P. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63471-2 · Cited by 444
Tall, A. R. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01898.x · Cited by 436
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
West, X. Z., Malinin, N. L., Merkulova, A. A., Tischenko, M., Kerr, B. A., Borden, E. C., Podrez, E. A., Salomon, R. G., & Byzova, T. V. (2010) · Nature · doi:10.1038/nature09421 · Cited by 431
Autoimmune and Inflammatory Mechanisms in Atherosclerosis
Wick, G., Knoflach, M., & Xu, Q. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104644 · Cited by 431
Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422
Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice
Smith, E., Prasad, K.-M. R., Butcher, M., Dobrian, A., Kolls, J. K., Ley, K., & Galkina, E. (2010) · Circulation · doi:10.1161/circulationaha.109.924886 · Cited by 421
Eid, R. E., Rao, D. A., Zhou, J., Lo, S.-F. L., Ranjbaran, H., Gallo, A., Sokol, S. I., Pfau, S., Pober, J. S., & Tellides, G. (2009) · Circulation · doi:10.1161/circulationaha.108.827618 · Cited by 412
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B., Perez, N., Yasukawa, H., Van Snick, J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090545 · Cited by 408
Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209634200 · Cited by 399
Gräbner, R., Lötzer, K., Döpping, S., Hildner, M., Radke, D., Beer, M., Spanbroek, R., Lippert, B., Reardon, C. A., Getz, G. S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20080752 · Cited by 397
Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E −/− Mice Through Release of Interferon-γ
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Circulation Research · doi:10.1161/hh0202.105292 · Cited by 385
Exogenous Interferon-γ Enhances Atherosclerosis in Apolipoprotein E−/− Mice
Whitman, S. C., Ravisankar, P., Elam, H., & Daugherty, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64820-1 · Cited by 378
Chemokines in Atherosclerosis: An Update
Zernecke, A., Shagdarsuren, E., & Weber, C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161174 · Cited by 376
The LDL modification hypothesis of atherogenesis: an update
Steinberg, D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800087-jlr200 · Cited by 375
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
Elhage, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00343-2 · Cited by 373
Cardiovascular Disease Risk Factors: Epidemiology and Risk Assessment
Dahlöf, B. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.007 · Cited by 359
Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
Erbel, C., Chen, L., Bea, F., Wangler, S., Celik, S., Lasitschka, F., Wang, Y., Böckler, D., Katus, H. A., & Dengler, T. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901126 · Cited by 358
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses
Buono, C., Binder, C. J., Stavrakis, G., Witztum, J. L., Glimcher, L. H., & Lichtman, A. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409015102 · Cited by 358
Ameli, S., Hultgårdh-Nilsson, A., Regnström, J., Calara, F., Yano, J., Cercek, B., Shah, P. K., & Nilsson, J. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.1074 · Cited by 355
Role of Naturally Occurring CD4 + CD25 + Regulatory T Cells in Experimental Atherosclerosis
Mor, A., Planer, D., Luboshits, G., Afek, A., Metzger, S., Chajek-Shaul, T., Keren, G., & George, J. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000259365.31469.89 · Cited by 348
Swanberg, M., Lidman, O., Padyukov, L., Eriksson, P., Åkesson, E., Jagodic, M., Lobell, A., Khademi, M., Börjesson, O., Lindgren, C. M., et al. (2005) · Nature Genetics · doi:10.1038/ng1544 · Cited by 339
The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells
Gargalovic, P. S., Gharavi, N. M., Clark, M. J., Pagnon, J., Yang, W.-P., He, A., Truong, A., Baruch-Oren, T., Berliner, J. A., Kirchgessner, T. G., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000242903.41158.a1 · Cited by 338
B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice
Major, A. S., Fazio, S., & Linton, M. F. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000039169.47943.ee · Cited by 329
Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
Gabriel, S. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.06.011 · Cited by 315
Kyaw, T., Tay, C., Khan, A., Dumouchel, V., Cao, A., To, K., Kehry, M., Dunn, R., Agrotis, A., Tipping, P., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000033 · Cited by 311
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
Lee, T.-S., Yen, H.-C., Pan, C.-C., & Chau, L.-Y. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 311
Adaptive immunity and atherosclerosis
Andersson, J., Libby, P., & Hansson, G. K. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.07.002 · Cited by 293
Self-citationBuono, C., Come, C. E., Stavrakis, G., Maguire, G. F., Connelly, P. W., & Lichtman, A. H. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000059419.11002.6e · Cited by 289
Wang, X., Ria, M., Kelmenson, P. M., Eriksson, P., Higgins, D. C., Samnegård, A., Petros, C., Rollins, J., Bennet, A. M., Wiman, B., et al. (2005) · Nature Genetics · doi:10.1038/ng1524 · Cited by 280
Maron, R., Sukhova, G., Faria, A.-M., Hoffmann, E., Mach, F., Libby, P., & Weiner, H. L. (2002) · Circulation · doi:10.1161/01.cir.0000029750.99462.30 · Cited by 267
King, V. L., Szilvassy, S. J., & Daugherty, A. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.104905 · Cited by 265
Tsimikas, S., Brilakis, E. S., Lennon, R. J., Miller, E. R., Witztum, J. L., McConnell, J. P., Kornman, K. S., & Berger, P. B. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600361-jlr200 · Cited by 260
Qiu, H., Gabrielsen, A., Agardh, H. E., Wan, M., Wetterholm, A., Wong, C.-H., Hedin, U., Swedenborg, J., Hansson, G. K., Samuelsson, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602414103 · Cited by 248
Self-citationThe macrophage scavenger receptor at 30 years of age: current knowledge and future challenges
Greaves, D. R., & Gordon, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800066-jlr200 · Cited by 248
Niessner, A., Sato, K., Chaikof, E. L., Colmegna, I., Goronzy, J. J., & Weyand, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.642801 · Cited by 243
Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
Hermansson, A., Ketelhuth, D. F. J., Strodthoff, D., Wurm, M., Hansson, E. M., Nicoletti, A., Paulsson-Berne, G., & Hansson, G. K. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092243 · Cited by 240
Self-citationProatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice
Gotsman, I., Grabie, N., Dacosta, R., Sukhova, G., Sharpe, A., & Lichtman, A. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31344 · Cited by 239
de Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M., & van der Wal, A. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000779 · Cited by 237
Bäck, M., Bu, D.-X., Bränström, R., Sheikine, Y., Yan, Z.-Q., & Hansson, G. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505845102 · Cited by 230
Self-citationEmerging role of Toll-like receptors in atherosclerosis
Curtiss, L. K., & Tobias, P. S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800056-jlr200 · Cited by 225
Olofsson, P. S., Söderström, L. A., Wågsäter, D., Sheikine, Y., Ocaya, P., Lang, F., Rabu, C., Chen, L., Rudling, M., Aukrust, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.699173 · Cited by 223
Self-citationABCA1 and ABCG1 Protect Against Oxidative Stress–Induced Macrophage Apoptosis During Efferocytosis
Yvan-Charvet, L., Pagler, T. A., Seimon, T. A., Thorp, E., Welch, C. L., Witztum, J. L., Tabas, I., & Tall, A. R. (2010) · Circulation Research · doi:10.1161/circresaha.110.217281 · Cited by 217
Huber, S. A., Sakkinen, P., David, C., Newell, M. K., & Tracy, R. P. (2001) · Circulation · doi:10.1161/01.cir.103.21.2610 · Cited by 211
Schiopu, A., Bengtsson, J., Söderberg, I., Janciauskiene, S., Lindgren, S., Ares, M. P. S., Shah, P. K., Carlsson, R., Nilsson, J., & Fredrikson, G. N. (2004) · Circulation · doi:10.1161/01.cir.0000143162.56057.b5 · Cited by 209
Bochkov, V. N., Mechtcheriakova, D., Lucerna, M., Huber, J., Malli, R., Graier, W. F., Hofer, E., Binder, B. R., & Leitinger, N. (2002) · Blood · doi:10.1182/blood.v99.1.199 · Cited by 201
Fredrikson, G. N., Hedblad, B., Berglund, G., Alm, R., Ares, M., Cercek, B., Chyu, K.-Y., Shah, P. K., & Nilsson, J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000067935.02679.b0 · Cited by 201
Klingenberg, R., Lebens, M., Hermansson, A., Fredrikson, G. N., Strodthoff, D., Rudling, M., Ketelhuth, D. F. J., Gerdes, N., Holmgren, J., Nilsson, J., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.202671 · Cited by 201
Self-citationOligoclonal T Cell Expansions in Atherosclerotic Lesions of Apolipoprotein E–Deficient Mice
Paulsson, G., Zhou, X., Törnquist, E., & Hansson, G. K. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.1.10 · Cited by 195
Self-citationInnate immune signals in atherosclerosis
Lundberg, A. M., & Hansson, G. K. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.07.016 · Cited by 194
Self-citationHermansson, A., Johansson, D. K., Ketelhuth, D. F. J., Andersson, J., Zhou, X., & Hansson, G. K. (2011) · Circulation · doi:10.1161/circulationaha.110.973222 · Cited by 189
Self-citationHarats, D., Yacov, N., Gilburd, B., Shoenfeld, Y., & George, J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02135-6 · Cited by 184
de Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M., Idu, M. M., van Maldegem, F., Aten, J., & van der Wal, A. C. (2010) · The Journal of Pathology · doi:10.1002/path.2667 · Cited by 183
Phosphorylcholine-Targeting Immunization Reduces Atherosclerosis
Caligiuri, G., Khallou-Laschet, J., Vandaele, M., Gaston, A.-T., Delignat, S., Mandet, C., Kohler, H. V., Kaveri, S. V., & Nicoletti, A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.054 · Cited by 182
Blockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis
Hauer, A. D., Uyttenhove, C., de Vos, P., Stroobant, V., Renauld, J. C., van Berkel, T. J. C., van Snick, J., & Kuiper, J. (2005) · Circulation · doi:10.1161/circulationaha.104.533463 · Cited by 182
Reardon, C. A., Blachowicz, L., White, T., Cabana, V., Wang, Y., Lukens, J., Bluestone, J., & Getz, G. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.1011 · Cited by 181
IFN- γ Deficiency Exerts Gender-Specific Effects on Atherogenesis in Apolipoprotein E -/- Mice
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260100141 · Cited by 176
Sasaki, N., Yamashita, T., Takeda, M., Shinohara, M., Nakajima, K., Tawa, H., Usui, T., & Hirata, K.-I. (2009) · Circulation · doi:10.1161/circulationaha.109.863431 · Cited by 170
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice
van Es, T., van Puijvelde, G. H. M., Ramos, O. H., Segers, F. M. E., Joosten, L. A., van den Berg, W. B., Michon, I. M., de Vos, P., van Berkel, T. J. C., & Kuiper, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.152 · Cited by 163
Nuclear Receptors and Inflammation Control: Molecular Mechanisms and Pathophysiological Relevance
Huang, W. J. M., & Glass, C. K. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191189 · Cited by 157
Zhou, X., Robertson, A.-K. L., Hjerpe, C., & Hansson, G. K. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000206122.61591.ff · Cited by 157
Self-citationInvolvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis
Edfeldt, K., Agerberth, B., Rottenberg, M. E., Gudmundsson, G. H., Wang, X.-B., Mandal, K., Xu, Q., & Yan, Z. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000223901.08459.57 · Cited by 148
Ludewig, B., Freigang, S., Jäggi, M., Kurrer, M. O., Pei, Y.-C., Vlk, L., Odermatt, B., Zinkernagel, R. M., & Hengartner, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220427097 · Cited by 144
Heller, E. A., Liu, E. H., Tager, A. M., Sinha, S., Roberts, J. D., Koehn, S. L., Libby, P., Aïkawa, E., Chen, J. Q., Huang, P. L., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.545616 · Cited by 143
European biologicals registers: methodology, selected results and perspectives
Zink, A., Askling, J., Dixon, W. G., Klareskog, L., Silman, A. J., & Symmons, D. P. M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091926 · Cited by 142
Gharavi, N. M., Alva, J. A., Mouillesseaux, K. P., Lai, C. K., Yeh, M. W., Yeung, W., Johnson, J. P., Szeto, W. L., Hong, L., Fishbein, M. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704267200 · Cited by 142
Dendritic cells in atherosclerotic disease
Niessner, A., & Weyand, C. M. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.05.006 · Cited by 141
King, V. L., Cassis, L. A., & Daugherty, A. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060857 · Cited by 139
Jury, E. C., Isenberg, D. A., Mauri, C., & Ehrenstein, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7416 · Cited by 136
Mast cells: multipotent local effector cells in atherothrombosis
Kovanen, P. T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00515.x · Cited by 133
Immunomodulation of Atherosclerosis: Implications for Vaccine Development—ATVB In Focus
Nilsson, J. Å., Hansson, G. K., & Shah, P. K. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000149142.42590.a2 · Cited by 123
Self-citationThe macrophage scavenger receptor type A directs modified proteins to antigen presentation
Nicoletti, A., Caligiuri, G., Törnberg, I., Kodama, T., Stemme, S., & Hansson, G. K. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<512::aid-immu512>3.0.co;2-y · Cited by 116
Self-citationVeillard, N. R., Steffens, S., Burger, F., Pelli, G., & Mach, F. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000146532.98235.e6 · Cited by 88
Antibody Titers Against Oxidized LDL Are Not Elevated in Patients With Familial Hypercholesterolemia
Hulthe, J., Wikstrand, J., Lidell, A., et al. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.8.1203 · Cited by 72
Targeted Deletions of Cyclooxygenase-2 and Atherogenesis in Mice
Hui, Y., Ricciotti, E., Crichton, I., Zhou, Y., Wang, D., Stubbe, J., Wang, M., Puré, E., & FitzGerald, G. A. (2010) · Circulation · doi:10.1161/circulationaha.109.910687 · Cited by 65
Hjerpe, C., Johansson, D. K., Hermansson, A., Hansson, G. K., & Zhou, X. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.003 · Cited by 52
Self-citationFredrikson, G. N., Hedblad, B., Berglund, G. L., Alm, R., Nilsson, J., Șchiopu, A., Shah, P. K., & Nilsson, J. Å. (2007) · Stroke · doi:10.1161/strokeaha.106.474577 · Cited by 47
Vliegen, I., Herngreen, S. B., Grauls, G. E. L. M., Bruggeman, C. A., & Stassen, F. R. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.035 · Cited by 46
Autoantibodies against modified low-density lipoproteins in coronary artery disease
Tornvall, P. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00021-2 · Cited by 41
TNF and congestive heart failure: therapeutic possibilities
Müller‐Ehmsen, J., & Schwinger, R. H. G. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.3.203 · Cited by 29
Statins in rheumatoid arthritis—two birds with one stone?
Klareskog, L., & Hamsten, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16485-4 · Cited by 23
Tackling Two Diseases with HDL
Hansson, G. K., & Björkholm, M. (2010) · Science · doi:10.1126/science.1191663 · Cited by 16
Self-citation
Cited by
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Atherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Damage-associated molecular patterns in inflammatory diseases
Roh, J. S., & Sohn, D. H. (2018) · Immune Network · doi:10.4110/in.2018.18.e27 · Cited by 1,261
Oxidative Stress in Atherosclerosis
Kattoor, A. J., Pothineni, N. V. K., Palagiri, D., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0678-6 · Cited by 1,266
Metadata
- Authors
- Hansson, G. K., & Hermansson, A.
- Venue
- Nature Immunology
- Published
- 2011-02-15
- Volume
- 12
- Issue
- 3
- Pages
- 204-212
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2008960002
- Cited by
- 2,317
- References
- 123
- FWCI
- 70.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.